496 related articles for article (PubMed ID: 31173266)
1. PTPN1 promotes the progression of glioma by activating the MAPK/ERK and PI3K/AKT pathways and is associated with poor patient survival.
Jin T; Li D; Yang T; Liu F; Kong J; Zhou Y
Oncol Rep; 2019 Aug; 42(2):717-725. PubMed ID: 31173266
[TBL] [Abstract][Full Text] [Related]
2. STYK1 promotes epithelial-mesenchymal transition and tumor metastasis in human hepatocellular carcinoma through MEK/ERK and PI3K/AKT signaling.
Wang Z; Qu L; Deng B; Sun X; Wu S; Liao J; Fan J; Peng Z
Sci Rep; 2016 Sep; 6():33205. PubMed ID: 27628214
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA LINC01426 promotes glioma progression through PI3K/AKT signaling pathway and serves as a prognostic biomarker.
Wang SJ; Wang H; Zhao CD; Li R
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6358-6368. PubMed ID: 30338804
[TBL] [Abstract][Full Text] [Related]
4. E2F2 drives glioma progression via PI3K/AKT in a PFKFB4-dependent manner.
Zhang L; Liu Z; Dong Y; Kong L
Life Sci; 2021 Jul; 276():119412. PubMed ID: 33774025
[TBL] [Abstract][Full Text] [Related]
5. INTS6 promotes colorectal cancer progression by activating of AKT and ERK signaling.
Ding X; Chen T; Shi Q; Nan P; Wang X; Xie D; Li J
Exp Cell Res; 2021 Oct; 407(2):112826. PubMed ID: 34508742
[TBL] [Abstract][Full Text] [Related]
6. CBX2 Induces Glioma Cell Proliferation and Invasion Through the Akt/PI3K Pathway.
Wang L; Ren B; Zhuang H; Zhong Y; Nan Y
Technol Cancer Res Treat; 2021; 20():15330338211045831. PubMed ID: 34709960
[TBL] [Abstract][Full Text] [Related]
7. Research on miR-126 in glioma targeted regulation of PTEN/PI3K/Akt and MDM2-p53 pathways.
Chen SR; Cai WP; Dai XJ; Guo AS; Chen HP; Lin GS; Lin RS
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3461-3470. PubMed ID: 31081101
[TBL] [Abstract][Full Text] [Related]
8. CAPN1 promotes malignant behavior and erlotinib resistance mediated by phosphorylation of c-Met and PIK3R2 via degrading PTPN1 in lung adenocarcinoma.
Chen Y; Tang J; Lu T; Liu F
Thorac Cancer; 2020 Jul; 11(7):1848-1860. PubMed ID: 32395869
[TBL] [Abstract][Full Text] [Related]
9. Effects of Fibronectin 1 on Cell Proliferation, Senescence and Apoptosis of Human Glioma Cells Through the PI3K/AKT Signaling Pathway.
Liao YX; Zhang ZP; Zhao J; Liu JP
Cell Physiol Biochem; 2018; 48(3):1382-1396. PubMed ID: 30048971
[TBL] [Abstract][Full Text] [Related]
10. miR-3175 and miR-134 affect proliferation, invasion and apoptosis of glioma cells through PI3K/AKT signaling pathway.
Qi A; Han J; Jia F; Liu C
J BUON; 2019; 24(6):2465-2474. PubMed ID: 31983121
[TBL] [Abstract][Full Text] [Related]
11. Epithelial membrane protein 1 promotes glioblastoma progression through the PI3K/AKT/mTOR signaling pathway.
Miao L; Jiang Z; Wang J; Yang N; Qi Q; Zhou W; Feng Z; Li W; Zhang Q; Huang B; Chen A; Zhang D; Zhao P; Li X
Oncol Rep; 2019 Aug; 42(2):605-614. PubMed ID: 31233190
[TBL] [Abstract][Full Text] [Related]
12. Metastatic function of BMP-2 in gastric cancer cells: the role of PI3K/AKT, MAPK, the NF-κB pathway, and MMP-9 expression.
Kang MH; Oh SC; Lee HJ; Kang HN; Kim JL; Kim JS; Yoo YA
Exp Cell Res; 2011 Jul; 317(12):1746-62. PubMed ID: 21570392
[TBL] [Abstract][Full Text] [Related]
13. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
Li Y; Ma X; Wang Y; Li G
Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210
[TBL] [Abstract][Full Text] [Related]
14. HULC long noncoding RNA silencing suppresses angiogenesis by regulating ESM-1 via the PI3K/Akt/mTOR signaling pathway in human gliomas.
Zhu Y; Zhang X; Qi L; Cai Y; Yang P; Xuan G; Jiang Y
Oncotarget; 2016 Mar; 7(12):14429-40. PubMed ID: 26894862
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of miR-770 indicates a favorable prognosis and suppresses tumorigenesis by modulating PI3K-AKT pathway in glioma.
Feng FQ; Liu GS; Li JC; Chen LZ
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2870-2879. PubMed ID: 31002138
[TBL] [Abstract][Full Text] [Related]
16. Remodeling cancer stemness by collagen/fibronectin
Zhong C; Tao B; Tang F; Yang X; Peng T; You J; Xia K; Xia X; Chen L; Peng L
Theranostics; 2021; 11(4):1991-2005. PubMed ID: 33408794
[TBL] [Abstract][Full Text] [Related]
17. TRAM2 promotes the malignant progression of glioma through PI3K/AKT/mTOR pathway.
Gao X; Jiang W; Ke Z; Huang Q; Chen L; Zhang G; Li C; Yu X
Biochem Biophys Res Commun; 2022 Jan; 586():34-41. PubMed ID: 34826698
[TBL] [Abstract][Full Text] [Related]
18. Enhanced Expression of TGFBI Promotes the Proliferation and Migration of Glioma Cells.
Guo SK; Shen MF; Yao HW; Liu YS
Cell Physiol Biochem; 2018; 49(3):1097-1109. PubMed ID: 30196284
[TBL] [Abstract][Full Text] [Related]
19. RUNX2 Plays An Oncogenic Role in Esophageal Carcinoma by Activating the PI3K/AKT and ERK Signaling Pathways.
Lu H; Jiang T; Ren K; Li ZL; Ren J; Wu G; Han X
Cell Physiol Biochem; 2018; 49(1):217-225. PubMed ID: 30138923
[TBL] [Abstract][Full Text] [Related]
20. RabGEF1 functions as an oncogene in U251 glioblastoma cells and is involved in regulating AKT and Erk pathways.
Fan H; Xin T; Dong X; Yang F; Zhang R; Feng S; He D; Guo H; Pang Q
Exp Mol Pathol; 2021 Feb; 118():104571. PubMed ID: 33166495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]